2 Amendments of Linea SØGAARD-LIDELL related to 2020/2071(INI)
Amendment 269 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Calls on the Commission and the Member States to take whateto preserver action is needed to restore European health sovereignty and local pharmaceutical manufacturing, giving prio vibrant research-based pharmaceutical industry on its territory to essential and strategic medicines; calls on the Commission to map out potential production sites in the EU;aking into account that EU remains by far the first world manufacturing region of active ingredients for on patent medicines
Amendment 470 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11a. Calls for strengthening of the European Medicines Market to speed up patients’ access to medicines, make care more affordable, maximise savings in national health budgets and avoid administrative burdens for pharmaceutical companies;